Skip to main content
Retour
Watch Compare

MANGOCEUTICALS, INC.

Qualité des données : 100%
MGRX
Nasdaq Services Health Services
0,34 €
0,00 € (0,00%)
Cap. Boursière: 5,77 M
Prix
0,35 €
Cap. Boursière
5,77 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -5,85 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-25,96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-118,05%
En dessous de la moyenne du secteur (-15,85%)
ROIC-81,47%
Net Margin-4526,76%
Op. Margin-3954,28%

Sécurité

Debt / Equity
N/A
Current Ratio0,74
Interest Coverage-174,20

Valorisation

PE (TTM)
-0,28
Au-dessus de la moyenne du secteur (-1,21)
P/B Ratio0,37
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (506 pairs)
Métrique Action Médiane du Secteur
P/E -0,3 -1,2
P/B 0,4 1,4
ROE % -118,1 -15,8
Net Margin % -4526,8 -18,3
Rev Growth 5Y % — 4,0
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 — 360 057,76 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -25,96% Revenue Growth (3Y) -21,04%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 456 021,0 Net Income (TTM) -20,64 M
ROE -118,05% ROA -110,47%
Gross Margin 54,91% Operating Margin -3954,28%
Net Margin -4526,76% Free Cash Flow (TTM) -5,85 M
ROIC -81,47% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,74
Interest Coverage -174,20 Asset Turnover 0,02
Working Capital -206 052 Tangible Book Value -191 053
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,28 Forward P/E N/A
P/B Ratio 0,37 P/S Ratio 12,65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -101,41%
Market Cap 5,77 M Enterprise Value 5,29 M
Per Share
EPS (Diluted TTM) -2,17 Revenue / Share 0,03
FCF / Share -0,35 OCF / Share -0,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 28,34%
SBC-Adj. FCF -7,16 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 456 021,0 615 873,0 731 493,0
Net Income -20,64 M -8,71 M -9,21 M
EPS (Diluted) -2,17 -4,84 -0,57
Gross Profit 250 386,0 379 964,0 431 501,0
Operating Income -18,03 M -7,97 M -9,22 M
EBITDA — — —
R&D Expenses — — —
SG&A Expenses — — —
D&A — 9 936,0 —
Interest Expense 103 513,0 -6 473,0 6 473,0
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 16,09 M 15,37 M 1,05 M
Total Liabilities 890 568,0 1,43 M 276 039,0
Shareholders' Equity 15,20 M 13,95 M 774 754,0
Total Debt — — —
Cash & Equivalents 1,49 M 58 653,0 739 006,0
Current Assets 1,55 M 75 595,0 818 460,0
Current Liabilities 890 568,0 1,43 M 211 078,0